4//SEC Filing
CTI BIOPHARMA CORP 4
Accession 0000891293-15-000029
CIK 0000891293operating
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 6:03 PM ET
Size
8.1 KB
Accession
0000891293-15-000029
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Common Stock
2015-07-27+300,000→ 300,000 total - Award
Performance Rights
2015-07-27+406,483→ 406,483 totalExercise: $0.00Exp: 2016-12-31→ Common Stock (406,483 underlying)
Footnotes (2)
- [F1]Restricted stock award will vest in three installments with one-third of the award on each of (i) July 27, 2016; (ii) July 27, 2017; and (iii) July 27, 2018, subject to the officer's continued service with the Company.
- [F2]This transaction represents a grant of performance-based restricted stock units pursuant to CTIC's long-term incentive program. The reporting person has been granted an award that is payable in shares of CTIC common stock upon the achievement of certain performance goals on or before December 31, 2016. Should such a goal be timely achieved, the number of shares payable will be determined by multiplying the payout percentage that has been assigned by CTIC to that goal multiplied by the number of shares of CTIC common stock issued and outstanding at the time that particular goal has been achieved. One such performance goal is the attainment by CTIC of a specified level of market capitalization. The units reported above reflect the 0.225% payout percentage that has been assigned by CTIC to this market capitalization goal for purposes of the reporting person's award multiplied by the number of shares of CTIC common stock issued and outstanding as of July 27, 2015.
Documents
Issuer
CTI BIOPHARMA CORP
CIK 0000891293
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000891293
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 6:03 PM ET
- Size
- 8.1 KB